STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo mist targets abdominal cancer with fewer side effects
Disease control Recruiting nowThis early-stage trial tests a technique called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. The goal is to see if this method is safe and reduces side effects for people with biliary tract cancer that has spre…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could your own immune cells fight liver cancer? new trial aims to find out
Disease control Recruiting nowThis study tests a new approach for people with advanced liver cancer that cannot be surgically removed. Participants receive radiation followed by an injection of their own specially trained immune cells (dendritic cells), a pneumonia vaccine to boost immunity, and immunotherapy…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis early-phase trial is testing whether combining a targeted radiation treatment (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be removed by surgery. The study will enrol…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC